- Chimeric Antigen Receptor-Engineered NK-92 Cells: An Off-the-Shelf Cellular Therapeutic for Targeted Elimination of Cancer Cells and Induction of Protective Antitumor Immunity
Congcong Zhang et al, 2017, Frontiers in Immunology CrossRef - Genetic Manipulation of NK Cells for Cancer Immunotherapy: Techniques and Clinical Implications
Mattias Carlsten et al, 2015, Frontiers in Immunology CrossRef - The Advances and Challenges of NK Cell-Based Cancer Immunotherapy
Synat Kang et al, 2021, Current Oncology CrossRef - Prolonged Culture of Vaccine-Primed Lymphocytes Results in Decreased Antitumor Killing and Change in Cytokine Secretion
Jeffrey J. Sussman et al, 2004, Cancer Research CrossRef - Role of Natural Killer Cells in HIV-Associated Malignancies
Fabio E. Leal et al, 2017, Frontiers in Immunology CrossRef - hIL-15-gene modified human natural killer cells (NKL-IL15) exhibit anti-human leukemia functions
Wen Jiang et al, 2018, Journal of Cancer Research and Clinical Oncology CrossRef - Advancement of chimeric antigen receptor-natural killer cells targeting hepatocellular carcinoma
Kai Dai et al, 2021, World Journal of Gastrointestinal Oncology CrossRef